IBDEI36C ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50683,2)
 ;;=^5001460
 ;;^UTILITY(U,$J,358.3,50684,0)
 ;;=C81.90^^193^2497^90
 ;;^UTILITY(U,$J,358.3,50684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50684,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,50684,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,50684,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,50685,0)
 ;;=D89.2^^193^2497^91
 ;;^UTILITY(U,$J,358.3,50685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50685,1,3,0)
 ;;=3^Hypergammaglobulenemia,Unspec
 ;;^UTILITY(U,$J,358.3,50685,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,50685,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,50686,0)
 ;;=D05.12^^193^2497^94
 ;;^UTILITY(U,$J,358.3,50686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50686,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,50686,1,4,0)
 ;;=4^D05.12
 ;;^UTILITY(U,$J,358.3,50686,2)
 ;;=^5001931
 ;;^UTILITY(U,$J,358.3,50687,0)
 ;;=D05.11^^193^2497^95
 ;;^UTILITY(U,$J,358.3,50687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50687,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,50687,1,4,0)
 ;;=4^D05.11
 ;;^UTILITY(U,$J,358.3,50687,2)
 ;;=^5001930
 ;;^UTILITY(U,$J,358.3,50688,0)
 ;;=D05.10^^193^2497^96
 ;;^UTILITY(U,$J,358.3,50688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50688,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,50688,1,4,0)
 ;;=4^D05.10
 ;;^UTILITY(U,$J,358.3,50688,2)
 ;;=^5001929
 ;;^UTILITY(U,$J,358.3,50689,0)
 ;;=D50.0^^193^2497^97
 ;;^UTILITY(U,$J,358.3,50689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50689,1,3,0)
 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
 ;;^UTILITY(U,$J,358.3,50689,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,50689,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,50690,0)
 ;;=D50.9^^193^2497^98
 ;;^UTILITY(U,$J,358.3,50690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50690,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,50690,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,50690,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,50691,0)
 ;;=C46.9^^193^2497^99
 ;;^UTILITY(U,$J,358.3,50691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50691,1,3,0)
 ;;=3^Kaposi's Sarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,50691,1,4,0)
 ;;=4^C46.9
 ;;^UTILITY(U,$J,358.3,50691,2)
 ;;=^5001108
 ;;^UTILITY(U,$J,358.3,50692,0)
 ;;=C22.0^^193^2497^100
 ;;^UTILITY(U,$J,358.3,50692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50692,1,3,0)
 ;;=3^Liver Cell Carcinoma
 ;;^UTILITY(U,$J,358.3,50692,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,50692,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,50693,0)
 ;;=D05.02^^193^2497^101
 ;;^UTILITY(U,$J,358.3,50693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50693,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,50693,1,4,0)
 ;;=4^D05.02
 ;;^UTILITY(U,$J,358.3,50693,2)
 ;;=^5001928
 ;;^UTILITY(U,$J,358.3,50694,0)
 ;;=D05.01^^193^2497^102
 ;;^UTILITY(U,$J,358.3,50694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50694,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,50694,1,4,0)
 ;;=4^D05.01
 ;;^UTILITY(U,$J,358.3,50694,2)
 ;;=^5001927
 ;;^UTILITY(U,$J,358.3,50695,0)
 ;;=D05.00^^193^2497^103
 ;;^UTILITY(U,$J,358.3,50695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50695,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,50695,1,4,0)
 ;;=4^D05.00
 ;;^UTILITY(U,$J,358.3,50695,2)
 ;;=^5001926
